Indici bursieri Piețe bursiere Simboluri Statistici

Simbol BNTX
BioNTech SE ADR

miercuri, 12 iunie 2024, ora 19:19:59 EEST (UTC + 3)

Simbol BNTX
Simbol BNTX
Simbol eToro BNTX
MarketWatch BNTX
Finviz BNTX
Yahoo Finance BNTX
Google Finance BNTX
TradingView BNTX
Investing.com BNTX
Wikipedia BioNTech
Denumire BioNTech SE ADR
Website biontech.de
Piața NASDAQ
ISIN US09075V1026
Sector Health Technology
Industrie Biotechnology
Monedă USD
Preț 115,3400 USD
Capitalizare bursieră 26,460 mld. USD
P/E 4,14
Beta 0,9571
EPS 26,5256
Profit anual -13,63%
Dată actualizare 13.06.2023


Descriere
BioNTech SE is a next-generation immunotherapy company, which treats cancer and other serious diseases. It exploits an array of discovery and therapeutic drug platforms for the development of novel biopharmaceuticals. The company's portfolio of infectious disease and oncology product candidates include FixVac, iNeST (Individualized Neoantigen Specific Immunotherapy), Intratumoral Immunotherapies, RiboMabs, RiboCytokines, CAR T Cell Platform, T Cell Receptor(TCR), Checkpoint Immunomodulator, Targeted Cancer Antibodies, and Small Molecule Immunomodulators. The company was founded by Christopher Huber, Ozlem Tureci and Ugur Sahin on June 2, 2008 and is headquartered in Mainz, Germany.


Istoric cotații

Data P/E Beta Capitalizare Dividend EPS Profit anual Preț
26.10.2021 14,55 0,0000 84,680 0,00% 20,2645 +253,08% $0,00
13.06.2023 4,14 0,9571 26,460 0,00% 26,5256 -13,63% $115,34



Pagină vizualizată de 86 ori și generată în 0,020376 secunde.